Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis (2022)

First Author: Yarmolinsky J
Attributed to:  Mendelian randomization to hypothesis-free causal inference funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1003897

PubMed Identifier: 35113855

Publication URI: http://europepmc.org/abstract/MED/35113855

Type: Journal Article/Review

Parent Publication: PLOS Medicine

Issue: 2

ISSN: 1549-1277